Annual Short Term Debt
$1.00 M
+$550.00 K+120.88%
31 December 2023
Summary:
Keros Therapeutics annual short term debt is currently $1.00 million, with the most recent change of +$550.00 thousand (+120.88%) on 31 December 2023. During the last 3 years, it has risen by +$582.00 thousand (+137.59%). KROS annual short term debt is now at all-time high.KROS Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$1.86 M
+$761.00 K+69.43%
30 September 2024
Summary:
Keros Therapeutics quarterly short term debt is currently $1.86 million, with the most recent change of +$761.00 thousand (+69.43%) on 30 September 2024. Over the past year, it has increased by +$1.25 million (+203.93%). KROS quarterly short term debt is now at all-time high.KROS Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KROS Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +120.9% | +203.9% |
| 3 y3 years | +137.6% | +120.3% |
| 5 y5 years | +505.4% | - |
KROS Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +137.6% | at high | |
| 5 y | 5 years | at high | +505.4% | at high | |
| alltime | all time | at high | +505.4% | at high |
Keros Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.86 M(+69.4%) |
| June 2024 | - | $1.10 M(+4.4%) |
| Mar 2024 | - | $1.05 M(+4.5%) |
| Dec 2023 | $1.00 M(+120.9%) | $1.00 M(+64.5%) |
| Sept 2023 | - | $611.00 K(>+9900.0%) |
| June 2023 | - | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $455.00 K | $455.00 K(0.0%) |
| Sept 2022 | - | $455.00 K(-32.1%) |
| June 2022 | - | $670.00 K(-24.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $884.00 K(+2.6%) |
| Dec 2021 | $862.00 K(+103.8%) | $862.00 K(+2.3%) |
| Sept 2021 | - | $843.00 K(+87.8%) |
| June 2021 | - | $449.00 K(+3.0%) |
| Mar 2021 | - | $436.00 K(+3.1%) |
| Dec 2020 | $423.00 K(+12.5%) | $423.00 K(+2.7%) |
| Sept 2020 | - | $412.00 K(+3.0%) |
| June 2020 | - | $400.00 K(+3.1%) |
| Mar 2020 | - | $388.00 K(+3.2%) |
| Dec 2019 | $376.00 K(+126.5%) | $376.00 K |
| Dec 2018 | $166.00 K | - |
FAQ
- What is Keros Therapeutics annual short term debt?
- What is the all time high annual short term debt for Keros Therapeutics?
- What is Keros Therapeutics annual short term debt year-on-year change?
- What is Keros Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Keros Therapeutics?
- What is Keros Therapeutics quarterly short term debt year-on-year change?
What is Keros Therapeutics annual short term debt?
The current annual short term debt of KROS is $1.00 M
What is the all time high annual short term debt for Keros Therapeutics?
Keros Therapeutics all-time high annual short term debt is $1.00 M
What is Keros Therapeutics annual short term debt year-on-year change?
Over the past year, KROS annual short term debt has changed by +$550.00 K (+120.88%)
What is Keros Therapeutics quarterly short term debt?
The current quarterly short term debt of KROS is $1.86 M
What is the all time high quarterly short term debt for Keros Therapeutics?
Keros Therapeutics all-time high quarterly short term debt is $1.86 M
What is Keros Therapeutics quarterly short term debt year-on-year change?
Over the past year, KROS quarterly short term debt has changed by +$1.25 M (+203.93%)